aica ribonucleotide and Cirrhosis, Liver

aica ribonucleotide has been researched along with Cirrhosis, Liver in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chai, Y; Dong, D; Hu, L; Liu, W; Lv, Y; Ma, T; Wu, R; Zhang, N; Zhu, H	1
Dong, Z; George, J; Hu, L; Lv, Y; Su, L; Wang, J; Wu, Y	1
Choi, YK; Jang, SY; Jeon, JH; Jeong, WI; Jung, GS; Kang, YN; Kim, MK; Lee, IK; Park, KG; Park, SY; Shin, EC	1
Andreelli, F; Foretz, M; Guigas, B; Hébrard, S; Lantier, L; Leclerc, J; Mounier, R; Viollet, B	1
Abarca-Quinones, J; da Silva Morais, A; Guigas, B; Horsmans, Y; Leclercq, IA; Stärkel, P; Viollet, B	1

Reviews

1 review(s) available for aica ribonucleotide and Cirrhosis, Liver

Article	Year
AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta physiologica (Oxford, England), 2009, Volume: 196, Issue:1 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Dyslipidemias; Energy Metabolism; Fatty Liver; Gluconeogenesis; Glucose; Homeostasis; Humans; Hypoglycemic Agents; Lipid Metabolism; Liver; Liver Cirrhosis; Mitochondria; Protein Conformation; Protein Subunits; Ribonucleotides	2009

Article

Year

AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.

Acta physiologica (Oxford, England), 2009, Volume: 196, Issue:1

Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Dyslipidemias; Energy Metabolism; Fatty Liver; Gluconeogenesis; Glucose; Homeostasis; Humans; Hypoglycemic Agents; Lipid Metabolism; Liver; Liver Cirrhosis; Mitochondria; Protein Conformation; Protein Subunits; Ribonucleotides

2009

Other Studies

4 other study(ies) available for aica ribonucleotide and Cirrhosis, Liver

Article	Year
AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats. Canadian journal of gastroenterology & hepatology, 2018, Volume: 2018 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Bile Ducts; Cholestasis; Chronic Disease; Disease Models, Animal; Kupffer Cells; Ligation; Liver; Liver Cirrhosis; NF-kappa B; Protective Agents; Rats; Ribonucleotides; Signal Transduction	2018
AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model. Journal of molecular medicine (Berlin, Germany), 2019, Volume: 97, Issue:3 Topics: Actins; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Bile Ducts; Disease Models, Animal; Endothelial Cells; Hepatic Stellate Cells; Hypertension, Portal; Ligation; Liver Cirrhosis; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Rats, Sprague-Dawley; Ribonucleotides; Signal Transduction; Transforming Growth Factor beta	2019
Small heterodimer partner attenuates profibrogenic features of hepatitis C virus-infected cells. Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:10 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Cell Line, Tumor; Gluconeogenesis; Hepacivirus; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Metformin; Receptors, Cytoplasmic and Nuclear; Ribonucleotides; Signal Transduction; Transforming Growth Factor beta	2015
Development of hepatic fibrosis occurs normally in AMPK-deficient mice. Clinical science (London, England : 1979), 2009, Dec-14, Volume: 118, Issue:6 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Transdifferentiation; Cells, Cultured; Female; Hepatic Stellate Cells; Immunohistochemistry; Liver Cirrhosis; Mice; Ribonucleotides; RNA	2009